Apollo Endosurgery, Inc.

NasdaqGM:APEN Lagerbericht

Marktkapitalisierung: US$579.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Apollo Endosurgery Management

Management Kriterienprüfungen 4/4

Wichtige Informationen

Chas McKhann

Geschäftsführender

US$2.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts19.8%
Amtszeit als Geschäftsführer2.1yrs
Eigentum des Geschäftsführers0.4%
Durchschnittliche Amtszeit des Managements4.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.2yrs

Jüngste Management Updates

Recent updates

Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Nov 30
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?

Aug 05
Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?

Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings

Aug 04

Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Mar 02
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?

Aug 04
Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?

Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy

Jun 28

Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?

May 05
Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?

Apollo Endosurgery EPS beats by $0.05, beats on revenue

May 04

A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)

Mar 24
A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)

What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?

Mar 03
What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?

Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares

Feb 10
Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares

We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt

Jan 31
We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt

Assessing Apollo Endosurgery

Dec 27

If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%

Dec 27
If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%

Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?

Dec 01
Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?

Apollo Endosurgery EPS beats by $0.10, beats on revenue

Nov 05

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Chas McKhann im Vergleich zu den Einnahmen von Apollo Endosurgery verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Dec 31 2022US$3mUS$550k

-US$40m

Sep 30 2022n/an/a

-US$41m

Jun 30 2022n/an/a

-US$36m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021US$9mUS$375k

-US$25m

Vergütung im Vergleich zum Markt: Chas's total compensation ($USD2.78M) is about average for companies of similar size in the US market ($USD2.67M).

Entschädigung vs. Einkommen: Chas's compensation has been consistent with company performance over the past year.

Geschäftsführer

Chas McKhann (53 yo)

2.1yrs

Amtszeit

US$2,780,544

Vergütung

Mr. Charles S. McKhann, also known as Chas, serves as President, Chief Executive Officer and Director at Apollo Endosurgery, Inc since March 01, 2021. He served as Chief Commercial Officer at Torax Medical...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Charles McKhann
CEO, President & Director2.1yrsUS$2.78m0.39%
$ 2.2m
Jeffrey Black
CFO, Secretary & Treasurer1.7yrsUS$1.34m0.18%
$ 1.0m
John Molesphini
Executive Vice President of Operations5yrsUS$662.23k0.079%
$ 460.8k
Sergey Kantsevoy
Co-Founder and Innovation Partnerno datakeine Datenkeine Daten
Anthony Kalloo
Co-Founder and Innovation Partnerno datakeine Datenkeine Daten
Robert Hawes
Co-Founder and Innovation Partnerno datakeine Datenkeine Daten
Peter Cotton
Co-Founder and Innovation Partner18.3yrskeine Datenkeine Daten
Christopher Gostout
Co-Founder & Chief Medical Officerno dataUS$1.16m0.062%
$ 361.2k
Sydney Chung
Co-Founder and Innovation Partnerno datakeine Datenkeine Daten
Pankaj Pasricha
Co-Founder18.3yrskeine Datenkeine Daten
John Gillings
Investor Relations Managerno datakeine Datenkeine Daten
Brian Szymczak
Vice President of Legal & Compliance3.6yrskeine Datenkeine Daten

4.3yrs

Durchschnittliche Betriebszugehörigkeit

53yo

Durchschnittliches Alter

Erfahrenes Management: APEN's management team is considered experienced (4.3 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Charles McKhann
CEO, President & Director2.1yrsUS$2.78m0.39%
$ 2.2m
John Barr
Independent Chairman of the Board4.1yrsUS$193.24k0.051%
$ 298.6k
Julie Shimer
Independent Director4.9yrsUS$164.49k0.038%
$ 218.0k
Richard McGaughy
Independent Director11.3yrsUS$165.15kkeine Daten
William McClellan
Independent Director8.9yrsUS$169.49k0.047%
$ 270.3k
Adrian Park
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Mark Talamini
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Santiago Horgan
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Jay Redan
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Steve McCarus
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Jeffrey Marks
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
David Pacitti
Independent Director5.4yrsUS$159.70k0.0067%
$ 38.9k

5.2yrs

Durchschnittliche Betriebszugehörigkeit

58.5yo

Durchschnittliches Alter

Erfahrener Vorstand: APEN's board of directors are considered experienced (5.2 years average tenure).